Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
{{custom_author.name}}, {{article.zuoZheEn}}
Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 | 〉 |